Gesham Magombedze

Gesham Magombedze

Gilead Sciences Inc. - California / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4395974
-
person_outline Gesham Magombedze's MOST POPULAR ARTICLES
1-) Drug-penetration gradients associated with acquired drug resistance in patients with tuberculosisK Dheda, L Lenders, G Magombedze, S Srivastava, P Raj, E Arning, ...American journal of respiratory and critical care medicine 198 (9), 1208-1219, 20181002018
2-) Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrenceJG Pasipanodya, D Ogbonna, BE Ferro, G Magombedze, S Srivastava, ...Antimicrobial agents and chemotherapy 61 (11), e01206-17, 2017872017
3-) Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesionsAA Ordonez, H Wang, G Magombedze, CA Ruiz-Bedoya, S Srivastava, ...Nature medicine 26 (4), 529-534, 20201072020
4-) Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosisS Srivastava, G Magombedze, T Koeuth, C Sherman, JG Pasipanodya, ...Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00751-17, 20171072017
5-) Cellular and population plasticity of helper CD4+ T cell responsesG Magombedze, PBJ Reddy, S Eda, VV GanusovFrontiers in physiology 4, 206, 2013952013